1. Results of a human factors experiment of the usability and patient acceptance of a new autoinjector in patients with rheumatoid arthritis
- Author
-
Schwarzenbach F, Dao Trong M, Grange L, Laurent PE, Abry H, Cotten J, and Granger C
- Subjects
Medicine (General) ,R5-920 - Abstract
Florence Schwarzenbach,1 Michèle Dao Trong,1 Laurent Grange,2 Philippe E Laurent,3 Herve Abry,4 Joël Cotten,5 Corinne Granger1 1Medical Affairs, Becton Dickinson Medical Pharmaceutical Systems, Le-Pont-de-Claix, France; 2Rheumatology Clinic, South University Hospital, Echirolles, France; 3Creabio-ra SAS, Centre Hospitalier, Givors, France; 4Commercial Development Self Administration/Injectable Systems, Becton Dickinson Medical Pharmaceutical Systems, Le-Pont-de-Claix, France; 5Marketing, Becton Dickinson Medical Pharmaceutical Systems, Le-Pont-de-Claix, France Purpose: This study evaluated the human factors affecting the ease of use of a disposable autoinjector developed for subcutaneous self-injections performed by patients with chronic diseases. Materials and methods: This was a randomized, single-center study conducted with 65 patients with rheumatoid arthritis. Patients performed six simulated injections. Assessments of patient device acceptance and device usability were made by patient reports and independent observations of compliance with the device instruction for use (IFU) following single injections and repeated injections. Results: A total of 390 simulated injections were performed. Patient device acceptance was high; more than 90% of patients found each of the tested criteria to be acceptable (>80% was required for statistical significance; P
- Published
- 2014